Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy-Reference-Cited by-同舟云学术

Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy

Published:2023-01-05 Issue:10 Volume:152 Page:2109-2122
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Boerner Thomas¹,Carr Rebecca A.¹,Hsu Meier²,Michel Alexa¹,Tan Kay See²,Vos Elvira¹,Sihag Smita¹,Bains Manjit S.¹,Ku Geoffrey Y.³,Wu Abraham J.⁴,Jones David R.¹,Molena Daniela¹^ORCID

Affiliation:

1. Thoracic Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA

2. Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York New York USA

3. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA

4. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34417

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

4. Recurrence risk after Ivor Lewis oesophagectomy for cancer

5. Treatment strategies in recurrent esophageal or junctional cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the clinical utilization of geriatric nutritional risk index in esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy;European Journal of Surgical Oncology;2024-05

2. Reply to: “Optimizing the clinical utilization of geriatric nutritional risk index in esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy”;European Journal of Surgical Oncology;2024-05

3. Esophageal cancer: current status and new insights from inflammatory markers – a brief review;Polish Journal of Surgery;2024-03-27

4. Accurate location describe and management of lymph node recurrence after esophagectomy for thoracic esophageal squamous cell carcinoma：a retrospective cohort study;International Journal of Surgery;2024-03-18

5. Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings;Cancers;2024-01-11